The Global Gene Expression Market is estimated to be valued at USD 16.56 Bn in 2025 and is expected to reach USD 23.61 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 5.2% from 2025 to ...

Cofactor Genomics, a commercial-stage diagnostics company transforming precision oncology through RNA-based predictive tests, today announced strategic investments from Labcorp and Ascension Ventures.

Researchers have developed a novel approach to detect ALS and predict survival by measuring genetic activity in blood cells, a study found.

The authors provide a useful integrated analytical approach to investigating MASLD focused on diverse multiomic integration methods. The strength of evidence for this new resource is solid, as ...

Researchers in Japan have shown that the mitochondrial protein COX7RP extends healthy lifespan in mice by enhancing ...

This year, our scientists offered new hope for treating neurodegeneration and obesity and dramatically improved the odds that ...

Delaram Pouyabahar is a Canadian based computational biologist whose planned postdoctoral move to Harvard University ...

One key component might be RNA, a molecular cousin of DNA found in every form of life on Earth, and now scientists say they have shown how it could have formed on our planet eons ago. But not everyone ...

Different teams need to make the same conclusion multiple times before a consensus is reached and the finding can be built ...

The human genome contains approximately 1,600 types of transcription factors responsible for regulating gene activity across ...

Resistance to venetoclax (Venclexta® and Venclyxto®, Abbvie / Genentech), the $2.5 billion blockbuster Chronic Lymphocytic ...

Resistance to venetoclax (Venclexta® and Venclyxto®, Abbvie / Genentech), the $2.5 billion blockbuster Chronic Lymphocytic Leukemia (CLL) therapy, is emerging as a ...